Literature DB >> 22595354

Impact of maximal safe resection on the clinical outcome of adults with craniopharyngiomas.

Min Ho Lee1, Se-Hwan Kim, Ho Jun Seoul, Do-Hyun Nam, Jung-Il Lee, Kwan Park, Jong-Hyun Kim, Doo-Sik Kong.   

Abstract

Recent studies suggest that subtotal resection (STR) followed by adjuvant radiation therapy is an appealing alternative to gross total resection (GTR) for craniopharyngioma, as STR provides similar tumor control without the associated endocrinological and behavioral morbidity. We have examined the impact of maximal safe resection on the clinical outcome of patients with craniopharyngioma. A total of 90 patients underwent surgical resection of craniopharyngioma at a single institution between January 1995 and April 2009. Sixty-one patients underwent GTR alone, four underwent GTR followed by adjuvant radiotherapy, 15 underwent STR alone, and 10 underwent partial removal followed by adjuvant radiotherapy. We analyzed and compared the clinical and endocrinological outcomes and radiological follow-up data of these patients. During the follow-up period, tumor recurrence following the initial resection occurred in 36 of 90 patients (40%). The repeat resection rate was higher in the STR group than the GTR group. Recurrence occurred in 20 of 61 patients (32.8%) from the GTR alone group, in 11 of 15 patients (73.3%) from the STR alone group, and in five of 10 (50%) patients from the STR with adjuvant radiation, such as radiotherapy or stereotactic radiosurgery, group (p=0.030). Maximal safe resection of craniopharyngioma leads to excellent local control. STR with adjuvant radiation therapy does not assure preservation of endocrine function, although it provides better local control than STR alone.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22595354     DOI: 10.1016/j.jocn.2011.09.033

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  5 in total

1.  Surgical aspects in craniopharyngioma treatment.

Authors:  Shingo Fujio; Tomoko Hanada; Masanori Yonenaga; Yushi Nagano; Mika Habu; Kazunori Arita; Koji Yoshimoto
Journal:  Innov Surg Sci       Date:  2020-10-30

2.  Proton therapy for craniopharyngioma in adults: a protocol for systematic review and meta-analysis.

Authors:  Pengtao Li; Jialing Wang; Aximujiang Axier; Kai Zhou; Jingwei Yun; Huayi Wang; Tingrong Zhang; Shaoshan Li
Journal:  BMJ Open       Date:  2021-06-01       Impact factor: 2.692

3.  Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects.

Authors:  Semi B Harrabi; Sebastian Adeberg; Thomas Welzel; Stefan Rieken; Daniel Habermehl; Jürgen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2014-09-16       Impact factor: 3.481

4.  Preliminary Study on Composition and Microstructure of Calcification in Craniopharyngiomas.

Authors:  Junxiang Peng; Songtao Qi; Jun Pan; Xi'an Zhang; Guanglong Huang; Danling Li
Journal:  J Craniofac Surg       Date:  2016-06       Impact factor: 1.046

5.  Development and Validation of Predicting Nomograms for Craniopharyngioma: A Retrospective, Multiple-Center, Cohort Study.

Authors:  Dingkang Xu; Qingjie Wei; Zhe Li; Yan Hu; Peizhu Hu; Shengqi Zhao; Dengpan Song; Shixiong Lei; Mingchu Zhang; Qiang Gao; Longxiao Zhang; Fangbo Lin; Yuchao Zuo; Xianzhi Liu; Mengzhao Feng; Chunxiao Ma; Fuyou Guo
Journal:  Front Oncol       Date:  2021-07-12       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.